Ezh2 在正常大脑颗粒神经元发育和中枢细胞瘤中延迟了差异化基因的激活
James Purzner1,2,3, Alexander S Brown3,4, Teresa Purzner1,2,3
1Division of Neurosurgery, Department of Surgery, Queen's University, Kingston, ON.
bioRxiv : the preprint server for biology
|November 28, 2024
概括
儿童脑髓母细胞瘤 (MB) 的差异化疗法可以通过向Ezh2.2来增强. 抑制Ezh2和迫使细胞周期退出同时促进MB细胞的神经元分化.
科学领域:
- 神经瘤学神经瘤学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 发展生物学 发展生物学
背景情况:
- 脑髓母细胞瘤 (MB) 是一种常见的儿科脑瘤,其Sonic Hedgehog (SHH) 亚型起源于小脑颗粒神经元.
- 强迫神经元分化为MB提供了潜在的治疗策略,特别是在细胞死亡途径受损 (TP53突变) 的情况下.
研究的目的:
- 研究大脑小粒细胞中神经元分化的表观遗传调节.
- 确定这种差异化过程的关键调节者.
主要方法:
- 使用高通量测序 (ChIP-seq) 进行染色体免疫沉,以识别与DNA结合的蛋白质和染色体修饰.
- 在正常颗粒神经元分化过程中研究了基因转录的变化.
- 在脑髓母细胞瘤细胞模型中使用了Ezh2抑制剂 (UNC1999) 和CDK4/6抑制剂 (Palbociclib).
主要成果:
- 在正常颗粒神经元分化过程中,超过一半的基因被上调调节,发现了以h2为媒介的H3K27me3修饰.
- 条件淘汰Ezh2启动了颗粒神经元前体细胞循环后退出的分化.
- Ezh2抑制与强制细胞周期退出结合,诱导了脑髓母细胞瘤细胞中的神经元分化.
结论:
- 在发育中的小脑颗粒神经元中,Ezh2 起作用为 mitotic 后分化的重要障碍.
- 将Ezh2抑制与细胞周期退出策略相结合,对脑髓母细胞瘤分化疗法具有前景.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K


